Fear of change is a key limiting factor that is slowing the adoption and value of AI across life sciences. It doesn't have to ...

As part of celebrating WWMT's 75th birthday, we're catching up with some of the people who have been part of television ...

We came across a bullish thesis on Moderna, Inc. (MRNA) on Natan’s Substack. In this article, we will summarize the bulls’ ...

Chemistry falls under the umbrella of natural sciences, alongside other fields like biology, geology and physics. Chemistry ...

Total construction starts were up 13% in May to a seasonally adjusted annual rate of $1.16 trillion, according to Dodge ...

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.

Novo Nordisk shows strong fundamentals and long-term return potential despite valuation concerns and US pricing risks. Find ...

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast of a dominant position in the lucrative oncology space. Oncology ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.

LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- The pharmaceutical manufacturing market size has grown rapidly in recent years. It substantially expanded from $519.78 ...

Following a disappointing performance from the company’s CAR-T candidate in an early-stage cancer trial, BioNTech is winding down cell therapy manufacturing at its inaugural U.S. plant. | Following a ...